Cardiovascular Diabetology

official impact factor 2.72

Open Access Highly Access

The role of interleukin-18 in the metabolic syndrome

Marius Trøseid*, Ingebjørg Seljeflot and Harald Arnesen

Cardiovascular Diabetology 2010, 9:11 doi:10.1186/1475-2840-9-11

Accesses  

  • Last 30 days: 121 accesses
  • Last 365 days: 1318 accesses
  • All time: 4483 accesses

Cited by

BioMed Central: 3 citations

Original investigation   Open Access

Effects of human immunodeficiency virus and metabolic complications on myocardial nutrient metabolism, blood flow, and oxygen consumption: a cross-sectional analysis

W Todd Cade, Dominic N Reeds, E Turner Overton, Pilar Herrero, Alan D Waggoner, Victor G Davila-Roman, Sherry Lassa-Claxton, Robert J Gropler, Pablo F Soto, Melissa J Krauss, Kevin E Yarasheski, Linda R Peterson Cardiovascular Diabetology 2011, 10:111 (8 December 2011)

Original investigation   Open Access

Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an Observational Study

Trine B Opstad, Alf Å Pettersen, Harald Arnesen, Ingebjørg Seljeflot Cardiovascular Diabetology 2011, 10:110 (5 December 2011)

Research   Open Access

Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome

Minako Yamaoka-Tojo, Taiki Tojo, Kazuki Wakaume, Ryo Kameda, Shinji Nemoto, Naonobu Takahira, Takashi Masuda, Tohru Izumi Nutrition & Metabolism 2011, 8:3 (20 January 2011)